4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-012393
EVP, General Counsel, Corp Sec sold 16,817 shares at an average $9.77 ($164,247)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP, General Counsel, Corp Sec | 2026-02-24 | Sale 10b5-1 | −3,117 | $9.53 | $29,713 | 126,682 | D |
| de Verneuil Vanina EVP, General Counsel, Corp Sec | 2026-02-25 | Sale 10b5-1 | −13,700 | $9.82 | $134,534 | 112,982 | D |
| Open-market sales · 16,817 sh · avg $9.77 · $164,247 | |||||||
Loading xslF345X05/wk-form4_1772142894.xml…